[Report of 100 pages] Cell models that represent normal or pathological lung physiology are known as lung in vitro models. When these cells are grown in a monolayer on a petri dish, they are referred to as 2D in vitro models. 3D models have a three-dimensional architecture and are supported by scaffolds and supports. 3D models are available commercially as ready-to-use in vitro models and can be built in-house utilising consumables.

The global in vitro lung model market was valued at USD 166.5 million in 2017 and is predicted to grow at a CAGR of 17.5 percent to USD 427.4 million by 2023.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78042820

Business Information
Additional market players will be profiled and analysed in detail (Up to 5)

The lung in vitro models market is expected to grow at a CAGR of 17.5 percent from USD 190.5 million in 2018 to USD 427.4 million in 2023. The development of innovative 3D in vitro models, as well as an increasing focus on providing alternatives to animal testing models, are driving the growth of this industry.

The report breaks down the market for lung in vitro models by type, application, and geography. The in vitro lung model market is divided into two types: 2D cell models and 3D cell models. In-house and marketed 3D cell models are the two types of 3D cell models (ready-to-use). Due to the growing demand for efficient lung in vitro models that replicate in vivo physiology, the 3D cell models segment is expected to develop at the quickest rate throughout the forecast period.

The market is divided into two types of applications: 2D models and 3D models. Drug discovery and toxicity, 3D model development, and basic research are all applications of 2D models. In 2018, the drug discovery and toxicology industry is projected to have the most 2D applications. Because of the versatility and high throughput capabilities of 2D cell models, drug development and toxicology applications dominated the 2D application area. Drug discovery and toxicity, physiological research, and stem cell research and regenerative medicine are all applications of 3D models. In 2018, the market for 3D lung in vitro models is likely to be dominated by drug development and toxicology applications.For drug research and toxicity applications, 3D cell models provide the relevant in vivo environment and reproducibility.

Request Sample:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=78042820

The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).